Buy Haloperidol

Haloperidol

Haloperidol: Generic Medication Overview

Haloperidol is an antipsychotic medication classified under the mental health therapeutic category. It is available as oral tablets (pill) in strengths of 5 mg and 10 mg. In Hong Kong, haloperidol is a prescription-only drug regulated by the Hong Kong Department of Health and follows international safety standards similar to those of the U.S. FDA and the European EMA. Commercially, it is also marketed under brand names such as Haldol.

How Haloperidol Works in the Body

Haloperidol belongs to the butyrophenone class of antipsychotics. It primarily blocks dopamine D₂ receptors in the brain, reducing excessive dopaminergic transmission that is associated with psychotic symptoms. By dampening dopamine activity, haloperidol helps to alleviate hallucinations, delusions, and severe agitation. The drug reaches peak plasma concentrations within 2-4 hours after oral ingestion, and its effects may last 12 hours or longer, allowing once- or twice-daily dosing.

Conditions Treated with Haloperidol

Haloperidol is approved for the management of several psychiatric conditions, including:

• Schizophrenia - to control acute psychotic episodes and maintenance therapy.
• Acute psychotic agitation - rapid calming of severe agitation in inpatient or emergency settings.
• Tourette syndrome - reduction of motor and vocal tics when other treatments are insufficient.

In Hong Kong, these indications are listed in the product’s prescribing information and align with approvals from other major regulatory agencies.

Off-Label and Investigational Applications

Evidence from peer-reviewed studies supports certain off-label uses of haloperidol, though they are not approved by regulatory agencies:

• Delirium - low-dose haloperidol is sometimes employed to manage hyperactive delirium in hospitalized patients.
• Nausea and vomiting - especially in palliative care settings where dopamine antagonism can be beneficial.

Off-label use requires medical supervision and an individualized risk assessment.

Who Should (Not) Use Haloperidol?

Absolute Contraindications

• Known hypersensitivity to haloperidol or any excipients.
• Patients receiving other high-potency antipsychotics with a risk of additive extrapyramidal effects.

Relative Contraindications

• Pregnancy - haloperidol is classified as Category C; use only if the potential benefit justifies the risk.
• Lactation - excreted in breast milk; consider alternatives.
• Severe liver impairment - reduced metabolism may increase plasma levels.
• Parkinson’s disease - dopamine blockade can worsen motor symptoms.

Special Populations

• Elderly - increased sensitivity to sedation and orthostatic hypotension; start at the lowest effective dose.
• Renal impairment - no dosage adjustment is required for mild to moderate dysfunction, but monitor for accumulation in severe cases.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Drowsiness or sedation.
• Dry mouth, constipation, or blurred vision.
• Mild extrapyramidal symptoms (e.g., tremor, rigidity).

Serious Adverse Events

• Neuroleptic malignant syndrome - a rare, life-threatening reaction characterized by fever, muscle rigidity, and autonomic instability.
• Tardive dyskinesia - persistent involuntary movements, more likely with long-term use.
• Cardiac QT prolongation - may increase the risk of arrhythmias, especially in patients with pre-existing heart conditions.

Drug Interactions

• Major: Co-administration with other dopamine antagonists or strong CYP3A4 inhibitors (e.g., ketoconazole) can raise haloperidol levels, increasing toxicity risk.
• Moderate: CNS depressants (benzodiazepines, alcohol) may enhance sedation.
• CYP Interactions: Haloperidol is metabolized mainly by CYP3A4 and CYP2D6; inducers like carbamazepine may lower its effectiveness.

Food and Lifestyle Interactions

• No specific food restrictions, but take the tablet with a full glass of water.
• Alcohol may intensify sedative effects; avoid excessive consumption.
• Caution when operating machinery or driving, especially during the initial treatment phase.

Patients should provide a complete medication list to their healthcare provider before starting haloperidol.

How to Take Haloperidol

• Standard dosing: Oral tablets are supplied in 5 mg and 10 mg strengths. Initial doses often start at 0.5-2 mg per day, divided as needed, with titration based on clinical response. Maintenance doses typically range from 5 mg to 20 mg daily, divided into one or two doses.
• Special populations:
• Elderly: Begin with the lowest possible dose (e.g., 0.5 mg).
• Hepatic impairment: Consider lower starting doses and monitor liver function.
• Administration: Swallow tablets whole; do not crush or chew.
• Missed dose: If a dose is missed and it is less than 12 hours until the next scheduled dose, take it as soon as remembered. Do not double the dose.
• Overdose: Symptoms may include severe drowsiness, rapid heartbeat, and seizures. Seek emergency medical care; treatment focuses on supportive measures and may involve the use of benzodiazepines for seizures.
• Discontinuation: Abrupt cessation can precipitate rebound psychosis or withdrawal dyskinesia. Taper the dose gradually under medical supervision when stopping therapy.

Monitoring and Follow-Up

• Baseline assessments: Complete physical exam, ECG (to evaluate QT interval), and liver function tests.
• Ongoing monitoring:
• Regular evaluation of psychiatric symptoms and side effect profile.
• Periodic ECGs for patients with cardiac risk factors.
• Assessment for extrapyramidal symptoms using standardized scales (e.g., AIMS).
• When to seek care: New or worsening fever, muscle rigidity, unexplained heart palpitations, or severe movement disorders.

Storage and Handling

• Store tablets at room temperature (20-25 °C), protected from moisture and light.
• Keep the container tightly closed and out of reach of children.
• Do not use tablets past the expiration date printed on the packaging.
• Dispose of unused medication according to local pharmacy take-back programs or Hong Kong waste-disposal guidelines.

Medication-Specific Glossary

D2 Receptor Antagonist

A drug that blocks dopamine D₂ receptors, thereby reducing dopaminergic neurotransmission.

Extrapyramidal Symptoms (EPS)

Drug-induced movement disorders such as tremor, rigidity, and dystonia, commonly associated with antipsychotics.

Neuroleptic Malignant Syndrome (NMS)

A rare but severe reaction to antipsychotics marked by hyperthermia, muscle rigidity, autonomic instability, and altered mental status.

Tardive Dyskinesia

Persistent, involuntary, repetitive movements that may develop after long-term exposure to dopamine-blocking agents.

Medical Disclaimer

This article provides educational information about haloperidol and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.